INSIGHTS ON CLINICAL TRIAL PARTNERING
-
Site Initiation Visits For Clinical Trials: Ocular Endpoint Planning For Sponsors And CROs
Learn how expert site initiation visit (SIV) planning masters complex endpoints like OCT and BCVA, eliminates data variability, and prevents the costly need for trial rescue.
-
TPDs: Developing The Next Generation Of Oral Therapeutics
Targeted Protein Degraders are a revolutionary drug class with challenges in bioavailability and formulation complexity. Strategic CDMO partnerships are key to successful, scalable development.
-
Targeted Modalities: Trends, Challenges, CDMO Considerations
Targeted modalities are designed to bind specifically to receptors or biological targets, ensuring a more directed and effective treatment while reducing systemic exposure and unintended side-effects.
-
Should Sponsors Provide Source Document Templates?
Here, we debate sponsor-provided source document templates, weighing regulatory guidance, compliance risks, and operational impacts for smarter clinical trial documentation decisions.
-
eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs6/17/2024
Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.
-
Breaking Free From Process Paralysis In Clinical Trials1/13/2025
Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.
-
Key Criteria For Choosing The Right Phase 1 CRO6/2/2025
What steps can you take to select the best CRO partner for your Phase 1 clinical trial?
-
A Turnkey Solution For Clinical Trials In Australia6/16/2025
This presentation is centered on Australia's unique value proposition in the global research landscape, emphasizing its ability to deliver high-quality trials with speed and efficiency.
-
Considerations For Subcutaneous, Intramuscular Formulation Development8/7/2025
Explore the changing landscape of parenteral delivery, considering the pros and cons of intravenous, subcutaneous, and intramuscular formulations, and how new technologies are reshaping drug delivery.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
For clinical trial technology vendors, it’s fast and easy to become part of the only industry-wide solution to sit tech overload.
-
The biggest issues for faltering trials? Incomplete planning and enrollment issues can explode into big problems if not addressed early enough. Biorasi offers a no-commitment, no-charge, fast consulting assessment that will identify and correct these issues in your study early – before they grow too big to manage.
-
We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials.
-
Our RegOps team offers document-level publishing or management of the entire regulatory submission process. Coupled with our electronic document management system (Veeva), we can oversee all technical aspects for submission of your dossier (eg, eCTD document granularity, utilization of content templates, document formatting, hyperlinking, bookmarks, navigation, publishing, and redaction services).
-
The full-service Contract Research Organization (CRO) with operations in Australia, New Zealand, Asia, North America, and Europe.